Is elevated cardiovascular risk a class effect of cyclo-oxygenase 2 inhibitors?
Year: 2006
Type: article
Author: Scott D Solomon
Institutions: Brigham and Women's Hospital, Harvard University
Language: English
Subfield: Pharmacology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2068349078
